+ |
CDK2 | up-regulates
phosphorylation
|
CCNA2 |
0.976 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-74466 |
Ser154 |
PMDGSFEsPHTMDMS |
Homo sapiens |
|
pmid |
sentence |
10652300 |
Here we present evidence from in vitro and in vivo assay systems that the degradation of human cyclin a can be inhibited by kinase-inactive mutants of cdk2 and cdc2cdk2 can phosphorylate cyclin a on ser-154 |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
NEK5 | up-regulates activity
binding
|
CCNA2 |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-273874 |
|
|
Homo sapiens |
MDA-MB-231 Cell |
pmid |
sentence |
30675923 |
NEK5 promotes breast cancer cell proliferation through up-regulation of Cyclin A2 |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
CDC25A | up-regulates activity
dephosphorylation
|
CCNA2 |
0.679 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-277136 |
|
|
Homo sapiens |
|
pmid |
sentence |
16682204 |
Cdc25A dephosphorylates and activates CyclinE\u2013Cdk2, CyclinA\u2013Cdk2 and CyclinB\u2013Cdk1, whereas Cdc25B and Cdc25C primarily target CyclinB\u2013Cdk1 [4,5] . |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
CCNA2 | form complex
binding
|
CyclinA2/CDK18 |
0.401 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-273437 |
|
|
|
|
pmid |
sentence |
33781185 |
PCTAIRE kinases (PCTKs) are a CDK subfamily, characterized by serine to cysteine mutation in the consensus PSTAIRE motif, involved in binding to the cyclin. One member of this class is PCTK3, which has two isoforms (a and b) and is also known as CDK18. After being activated by cyclin A2 or phosphorylation at Ser12 by PKA, PCTK3 can perform several functions. |
|
Publications: |
1 |
+ |
HMGA2 | up-regulates quantity by expression
transcriptional regulation
|
CCNA2 |
0.318 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-119496 |
|
|
Homo sapiens |
|
pmid |
sentence |
14645522 |
Transcriptional activation of the cyclin a gene by the architectural transcription factor hmga2 |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
TGFB1 | down-regulates quantity by repression
transcriptional regulation
|
CCNA2 |
0.289 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-29516 |
|
|
Homo sapiens |
|
pmid |
sentence |
7592630 |
Expression of one of these components, cyclin a, is inhibited by tgf-beta treatment. We have identified a 760-base pair fragment of the human cyclin a gene promoter that is sufficient to confer tgf-beta responsiveness. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
SMARCB1 | down-regulates
|
CCNA2 |
0.351 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-92782 |
|
|
Homo sapiens |
|
pmid |
sentence |
12226744 |
We show that the ectopic expression of wild-type hsnf5/ini1, but not that of truncated versions, leads to a cell cycle arrest by inhibiting the entry into s phase of mrt cells. This g1 arrest is associated with down-regulation of a subset of e2f targets including cyclin a, e2f1 and cdc6. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
MYC | up-regulates quantity by expression
transcriptional regulation
|
CCNA2 |
0.429 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-102728 |
|
|
Homo sapiens |
Leukemia Cell |
pmid |
sentence |
12835716 |
These results suggest that e2f1 and cyclin a2 may be induced by c-myc to mediate the onset of mammary cancer, whereas overexpression of cyclins d1 and e may occur later to facilitate tumor progression. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
CCNA2 | form complex
binding
|
CyclinA2/CDK1 |
0.919 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-267571 |
|
|
Homo sapiens |
|
pmid |
sentence |
29870721 |
Here we show that cyclin A/cdk1 kinase is the factor triggering mitosis. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
seliciclib | down-regulates
chemical inhibition
|
CCNA2 |
0.8 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-206559 |
|
|
Homo sapiens |
|
pmid |
sentence |
Other |
|
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
APC-c | down-regulates quantity by destabilization
ubiquitination
|
CCNA2 |
0.539 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-265050 |
|
|
|
|
pmid |
sentence |
21596315 |
Complexed with the activator proteins CDC20 or CDH1 (Fang et al., 1998, Visintin et al., 1997), the APC/C recognizes, ubiquitinates, and targets for proteasomal degradation a multitude of cell cycle regulators containing KEN or D box degrons, including securin, cyclin A, and cyclin B. |
|
Publications: |
1 |
+ |
4-[[5-amino-1-[(2,6-difluorophenyl)-oxomethyl]-1,2,4-triazol-3-yl]amino]benzenesulfonamide | down-regulates
chemical inhibition
|
CCNA2 |
0.8 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-193537 |
|
|
Homo sapiens |
|
pmid |
sentence |
Other |
|
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
YAP/TAZ | up-regulates quantity by expression
transcriptional regulation
|
CCNA2 |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-276575 |
|
|
|
|
pmid |
sentence |
30224758 |
By gene expression, exogenous YAP turns on its targets, but not in cells treated with JQ1 or depleted of BET-proteins (Fig. 3b and Supplementary Fig. 3e), indicating that BRD4 operates downstream of YAP/TAZ. |
|
Publications: |
1 |
+ |
4-(2,6-dichlorobenzamido)-N-(piperidin-4-yl)-pyrazole-3-carboxamide | down-regulates
chemical inhibition
|
CCNA2 |
0.8 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-189966 |
|
|
Homo sapiens |
|
pmid |
sentence |
Other |
|
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
PHA-848125 | down-regulates
chemical inhibition
|
CCNA2 |
0.8 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-206148 |
|
|
Homo sapiens |
|
pmid |
sentence |
Other |
|
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
YAP1 | up-regulates quantity by expression
transcriptional regulation
|
CCNA2 |
0.33 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-276563 |
|
|
|
|
pmid |
sentence |
30224758 |
By gene expression, exogenous YAP turns on its targets, but not in cells treated with JQ1 or depleted of BET-proteins (Fig. 3b and Supplementary Fig. 3e), indicating that BRD4 operates downstream of YAP/TAZ. |
|
Publications: |
1 |
Tissue: |
MCF-10A Cell |
+ |
CCNA2 | form complex
binding
|
CyclinA2/CDK2 |
0.976 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-182566 |
|
|
Homo sapiens |
|
pmid |
sentence |
19056339 |
We therefore compared human cyclin a1- and cyclin a2-containing cdk complexes in vitro by determining kinetic constants and by examining the complexes for their ability to phosphorylate prb and p53. Differences in biochemical activity were observed in cdk2 but not cdk1 when complexed with cyclin a1 versus cyclin a2. Further, cdk1/cyclin a1 is a better kinase complex for phosphorylating potentially physiologically relevant substrates prb and p53 than cdk2/cyclin a2. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
USP37 | up-regulates quantity by stabilization
deubiquitination
|
CCNA2 |
0.562 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-265052 |
|
|
Homo sapiens |
HEK-293 Cell |
pmid |
sentence |
21596315 |
USP37 Binds, Deubiquitinates, and Stabilizes Cyclin A |
|
Publications: |
1 |
Organism: |
Homo Sapiens |